CEO Raymond Dolan bought 1,000,000 shares of the Sonus Networks, Inc. (NASDAQ:SONS) stock in a transaction that occurred on Tuesday, April 29th. The stock was purchased at an average cost of $2.98 per share, with a total value of $2,980,000.00. Following the acquisition, the chief executive officer now directly owns 3,078,674 shares of the company’s stock, valued at approximately $9,174,449. Sonus Networks, Inc. (NASDAQ:SONS) shares after opening at $3.24 moved to $3.28 on last trade day and at the end of the day closed at $3.28. Company price to sales ratio in past twelve months was calculated as 2.77 and price to cash ratio as 4.95. Sonus Networks, Inc. (NASDAQ:SONS) showed a positive weekly performance of 3.58%.
In other Equinix news, major shareholder Advisory Corp Spo bought 74,900 shares of Equinix Inc (NASDAQ:EQIX) stock in a transaction dated Monday, April 28th. The stock was purchased at an average cost of $178.56 per share, for a total transaction of $13,374,144.00. Equinix Inc (NASDAQ:EQIX) shares fell -1.16% in last trading session and ended the day on $186.83. EQIZ return on equity ratio is recorded as 5.50% and its return on assets is 1.80%. Equinix Inc (NASDAQ:EQIX) yearly performance is -13.06%.
Zix Corp. (NASDAQ:ZIXI) Director Mark Bonney bought 5,000 shares of the company’s stock in a transaction dated Thursday, April 24th. The stock was purchased at an average cost of $3.50 per share, with a total value of $17,500.00. Following the acquisition, the director now directly owns 10,000 shares in the company, valued at approximately $35,000. Zix Corporation (NASDAQ:ZIXI) shares moved down -1.81% in last trading session and was closed at $3.26, while trading in range of $ 3.24 – 3.40. Zix Corporation (NASDAQ:ZIXI) year to date (YTD) performance is -28.51%.
MedAssets (NASDAQ:MDAS) Director R Halsey Wise purchased 8,950 shares of the company’s stock on the open market in a transaction dated Friday, May 2nd. The stock was purchased at an average price of $22.31 per share, for a total transaction of $199,674.50. Following the acquisition, the director now directly owns 8,950 shares of the company’s stock, valued at approximately $199,675. MedAssets, Inc. (NASDAQ:MDAS) weekly performance is -4.91%. On last trading day company shares ended up $22.10. MedAssets, Inc. (NASDAQ:MDAS) distance from 50-day simple moving average (SMA50) is -8.27%. Analysts mean target price for the company is $26.14.